Development and validation of prognostic markers in sarcomas base on a multi-omics analysis
Abstract Background In sarcomas, the DNA copy number and DNA methylation exhibit genomic aberrations. Transcriptome imbalances play a driving role in the heterogeneous progression of sarcomas. However, it is still unclear whether abnormalities of DNA copy numbers are systematically related to epigen...
Main Authors: | Yongchun Song, Kui Yang, Tuanhe Sun, Ruixiang Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12920-021-00876-4 |
Similar Items
-
Searching for a signature involving 10 genes to predict the survival of patients with acute myelocytic leukemia through a combined multi-omics analysis
by: Haifeng Zhuang, et al.
Published: (2020-06-01) -
Identification of Tumor Microenvironment-Related Prognostic Genes in Sarcoma
by: Dongjun Dai, et al.
Published: (2021-02-01) -
Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma
by: Talip Zengin, et al.
Published: (2020-09-01) -
Multi-Omics Analysis of the Effects of Smoking on Human Tumors
by: Rui Wang, et al.
Published: (2021-11-01) -
ConanVarvar: a versatile tool for the detection of large syndromic copy number variation from whole-genome sequencing data
by: Mikhail Gudkov, et al.
Published: (2023-02-01)